HRT Financial’s Leverage Shares 2X Long CRCL Daily ETF CRCG Stock Holding History

HRT Financial’s Portfolio CRCG Stock Details CRCG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,648	Closed	-$208K	–	5722
2026 Q1	$208K	Buy	7,648 +3,590	+88%	+$97K	﹤0.01%	3178
2025 Q4	$105K	Buy	+4,058	New	+$222K	﹤0.01%	2785

Other funds holding CRCG

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

GFG

Genesis Financial Group Paramus, New Jersey $154M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

HRT Financial's CRCG Position: Q2 2026 in Review

HRT Financial sold out of Leverage Shares 2X Long CRCL Daily ETF (CRCG) in Q2 2026, closing a stake of 7,648 shares — an estimated $208K sold.

HRT Financial first reported a position in CRCG in Q4 2025 and held it in 2 quarters. The position peaked at $208K in Q1 2026. 8 funds tracked by Wall St. Rank hold CRCG as of Q2 2026.

HRT Financial reported no remaining Leverage Shares 2X Long CRCL Daily ETF position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 7,648 Leverage Shares 2X Long CRCL Daily ETF shares in Q2 2026, an estimated $208K.
HRT Financial first reported a position in Leverage Shares 2X Long CRCL Daily ETF in Q4 2025 and held it in 2 quarters.
HRT Financial's Leverage Shares 2X Long CRCL Daily ETF position peaked at $208K in Q1 2026.
8 funds tracked by Wall St. Rank held Leverage Shares 2X Long CRCL Daily ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.